Donna Fezler wrote:
> Since I have completed the process twice, I am more confused. How did you
> get a copy of it ? Does it have a patent number? If it does it has been
> issued-the final step-but I did a patent search and it is not there.
> Confidentiality of patent contents is prudent until issuance, so I am
> wondering why they published it. If they were announcing a patent pending
> application they should have been very general, not publishing the specific
> application. Something is funny here.
>
> The patent process is not open to official public debate, unfortunately. It
> isn't even open to congressional influence to expedite the patent. I tried
> since I couldn't license it without the actual patent number. However, part
> of my struggle with the autoimmune patent came from the USPTO efforts
> (according to the patent attorney) to stem the tide of transgenic and plant
> patents. A media ruckus couldn't hurt focus attention on the situation
> indirectly.
>
> Donna Fezler
> GCR
> Jacksonville, IL
>
> http://www.rhealiving.com
>
> -----Original Message-----
> From: wytze [mailto:geno@zap.a2000.nl]
> Sent: Sunday, December 19, 1999 2:47 PM
> To: gcr@rhealiving.com
> Cc: sanet-mg@ces.ncsu.edu
> Subject: Re: New Novartis Patent VI
>
> As far as I understand it is not yet approved. It is an application and I
> hope
> to find out if comments to the patent offices are possible.
> In the mean time, the fun of this patent is that it reveals a huge amount of
> things so thank you Novartis for this information.
> Wytze
>
> Donna Fezler wrote:
>
> > It was filed on January 15, 1999 and it has been approved already?
> > Supposedly the USPTO is above corruption, but it usually takes at least 18
> > months for the first review. 95 % of patents are rejected at the first
> > review. It takes about 6 months from approval to issuance, so this patent
> > was reviewed and approved within 5 months of application. HMMM.
> >
> > Donna Fezler
> > GCR
> > Jacksonville, IL
> >
> > http://www.rhealiving.com
> >
> > -----Original Message-----
> > From: owner-sanet-mg@ces.ncsu.edu [mailto:owner-sanet-mg@ces.ncsu.edu]On
> > Behalf Of wytze
> > Sent: Sunday, December 19, 1999 12:27 PM
> > To: mmiller@pcsia.com
> > Cc: sanet-mg@ces.ncsu.edu
> > Subject: Re: New Novartis Patent VI
> >
> > I wonder if this mycotoxin story did not come up as a result of the
> patent,
> > given
> > the fact that the patent was filed 14 january 1999.
> > Furthermore, the "advantage" of increased pollination may be a great
> comfort
> > to
> > all of us.
> > I also wonder where the New Scientist got the 20% yield increase. It is
> not
> > mentioned in the patent.
> > wytze
> > P.S. I loved your new patent ideas!
> >
> > mmiller@pcsia.com wrote:
> >
> > > >Synergistic effects and advantages of the "invention" as described in
> > > >patent WO9935913.
> > > The term
> > > >"synergistic", however, is in no way to be understood in this
> connection
> > > >as being restricted to the pesticidal activity, but the term also
> refers
> > > >to other advantageous properties of the method according to the
> > > >invention compared with the nitroimino- or nitroguanidino-compound and
> > > >the transgenic useful plant alone.
> > > >Examples of such advantageous properties which may be mentioned are:
> > >
> > > >-enhanced crop safety; snip
> > > > reduced content of toxic products such as mycotoxins, snip
> > >
> > > I wonder what the people who published the mycotoxin discovery think
> about
> > > their idea being part of somebodyelse's patent?
> > >
> > > Also how much of the legal cost to determine what percentage of the
> > reduced
> > > mycotoxin benefit is attributable to the BT and what is due to the
> > > pesticide synergy (and then there are those pesky changes in that
> > > relationship as a function of soil type, weather conditions and other
> > > factors like carrier insect populations) will be passed onto the end
> users
> > > as higher food costs?
> > >
> > > Or maybe as in another industry I was in, just the fact that a large
> > > corporation has managed to get a patent from the new improved and
> defunded
> > > Patent Office that includes a prior art idea will be enough to not only
> > > keep them from using the prior art idea but will keep them from even
> > > challangeing the illegal patent due to lack of resources to do legal
> > battle
> > > with a large corporation.
> > >
> > > On the level of no moral constraints in the battle of corporations, this
> > > patent is a Very Beautiful Strategy. Think of it,
> > >
> > > I patent how people can use your products including the use of your
> > > pesticide on your herbicide and pesticide resistant crops.
> > >
> > > I now control how your customers can use your products through the
> license
> > > they are required to buy from me due to my patent on the use of your
> > products.
> > >
> > > So the question becomes : "How much of your value stream to your
> customers
> > > will I take in license fees? "
> > >
> > > I love it. This system may very well collapse under the weight of its
> own
> > > avarice. "Plutocracy today, plutocracy tomorrow, plutocracy forever"
> with
> > > apologies to George Wallace. Mike Miller
> > >
> > > To Unsubscribe: Email majordomo@ces.ncsu.edu with the command
> > > "unsubscribe sanet-mg". If you receive the digest format, use the
> command
> > > "unsubscribe sanet-mg-digest".
> > > To Subscribe to Digest: Email majordomo@ces.ncsu.edu with the command
> > > "subscribe sanet-mg-digest".
> > >
> > > All messages to sanet-mg are archived at:
> > > http://www.sare.org/htdocs/hypermail
> >
> > To Unsubscribe: Email majordomo@ces.ncsu.edu with the command
> > "unsubscribe sanet-mg". If you receive the digest format, use the command
> > "unsubscribe sanet-mg-digest".
> > To Subscribe to Digest: Email majordomo@ces.ncsu.edu with the command
> > "subscribe sanet-mg-digest".
> >
> > All messages to sanet-mg are archived at:
> > http://www.sare.org/htdocs/hypermail
>
> To Unsubscribe: Email majordomo@ces.ncsu.edu with the command
> "unsubscribe sanet-mg". If you receive the digest format, use the command
> "unsubscribe sanet-mg-digest".
> To Subscribe to Digest: Email majordomo@ces.ncsu.edu with the command
> "subscribe sanet-mg-digest".
>
> All messages to sanet-mg are archived at:
> http://www.sare.org/htdocs/hypermail
To Unsubscribe: Email majordomo@ces.ncsu.edu with the command
"unsubscribe sanet-mg". If you receive the digest format, use the command
"unsubscribe sanet-mg-digest".
To Subscribe to Digest: Email majordomo@ces.ncsu.edu with the command
"subscribe sanet-mg-digest".
All messages to sanet-mg are archived at:
http://www.sare.org/htdocs/hypermail